US4898592A - Means for the application of transdermally absorbable active substances - Google Patents

Means for the application of transdermally absorbable active substances Download PDF

Info

Publication number
US4898592A
US4898592A US07/245,923 US24592388A US4898592A US 4898592 A US4898592 A US 4898592A US 24592388 A US24592388 A US 24592388A US 4898592 A US4898592 A US 4898592A
Authority
US
United States
Prior art keywords
foam layer
carrier
skin
support
area
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US07/245,923
Inventor
Arno W. Latzke
Ralf Latzke
Gert Latzke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19863629565 external-priority patent/DE3629565A1/en
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of US4898592A publication Critical patent/US4898592A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02Compresses or poultices for effecting heating or cooling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0001Body part
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02Compresses or poultices for effecting heating or cooling
    • A61F2007/0203Cataplasms, poultices or compresses, characterised by their contents; Bags therefor
    • A61F2007/0215Cataplasms, poultices or compresses, characterised by their contents; Bags therefor containing liquids other than water
    • A61F2007/0217Oils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02Compresses or poultices for effecting heating or cooling
    • A61F2007/0261Compresses or poultices for effecting heating or cooling medicated

Definitions

  • the present invention relates to a device for the application of transdermally absorbable active substances which allows an intensive and sustained action of the transdermally absorbable active substances over a long period of time and increases the efficiency thereof by simultaneous action of heat.
  • a number of pains, cramps and convulsive disorders are caused by an insufficient or non-uniform blood flow in the outer skin.
  • alleviation, improvement or even healing may be achieved by a uniform application of heat.
  • the treatment with infrared radiation, warming bottles, heating pads, hot packs and cataplasms always involves considerable trouble and therefore is not always or readily practicable.
  • transdermally absorbable active substances such as, more specifically, oils of officinal herbs
  • transdermally absorbable active substances are therapeutically active, particularly when they can display their action over a sufficiently long period of time and have the opportunity of penetrating into the skin.
  • transdermally absorbable active substances such as, more specifically, oils of officinal herbs
  • transdermally absorbable active substances which means consist of at least one replaceable carrier (1) impregnated with the transdermally absorbable active substances and a support (2) for the carrier consisting of a laminate comprising
  • a closed-cell polyethylene foam layer (6) having a thickness of 1 to 4 mm, which may optionally be surface texturizing, from which at least one portion (7), preferably in pinked shape, has been punched, the size of the area of the portion (7) being equal to or slightly larger than that of the carrier (1), or
  • a closed-cell polyethylene foam layer (6) having a thickness of 2 to 5 mm, which may optionally be surface texturized, from which at least one portion (7), preferably in pinked shape, has been punched, the size of the area of the portion (7) being equal to or slightly larger than that of the carrier (1), or
  • the means preferably have a fabric layer (8) on the foam layer (3), which preferably consists of Borsched nylon.
  • This fabric layer allows the means of the invention to be attached to the body by use of skin-compatible self-adhesive plasters or elastic bandages having Velcro or interlocking hook-and-loop type fastners strip fasteners.
  • the device of the invention may be manufactured in the form of plasters, head-bands or pads, with head-bands and pads comprising several punched pieces (7) and carriers (1) impregnated with transdermally absorbable active substances and replaceably inserted therein.
  • the carriers (1) there may preferably be used nonwoven fabrics and, more specifically, any skin-compatible random laid nonwoven fabric having a sufficient rigidity which can be impregnated with the transdermally absorbable active ingredients.
  • any other sufficiently rigid skin-compatible absorptive carriers which are resistant to transdermally absorbable active substances such as, open-cell foams, fabric etc.
  • the shape of said impregnated carriers may be selected as desired and, for example, be square, rectangular or polygonal. Particularly simple and preferred is the circular shape.
  • These carriers impregnated with transdermally absorbable active substances either may be freshly prepared by the user or may be supplied sealed in a bag--like refreshment cloths--from the manufacturer.
  • the size of the punched pieces (7) is equal in area or slightly larger than that of the carrier (1) and is preferrably pinked. This shape provides a good support of the carrier in the recess and, in addition, favors the formation of air chambers at the margin of the carrier in which vapors of the transdermally absorbable substance may accumulate.
  • the closed-cell polyethylene foam layers (3), (5) and (6) may vary in thickness within the ranges as indicated between 1 and 5 mm or 1 and 6 mm, respectively, while the laminate altogether should be between 5 and 12 mm, and preferably between 6 and 10 mm, in thickness. Thinner laminates are difficult to manufacture and do not provide sufficient storage of heat. Thicker laminates will be too rigid and unhandy and too bulky.
  • the flexible heat-conductive metal foil there is mainly used aluminum foil which is preferably 20 to 50 micrometers in thickness.
  • the foam layer (5) is omitted, so that the carrier (1) has direct contact with the metal foil (4). This may result in even a more rapid and higher warming of the carrier (1) and, thus, the effect is induced more rapidly and is stronger.
  • the metal film (4) in the support laminate (2) it is also possible to omit the metal film (4) in the support laminate (2) altogether, if the absorptive carrier on one side is firmly bonded to the flexible heatconductive metal foil (4).
  • the two remaining foam layers (3) and (6) are different in color.
  • the layer (3) is selected so that it is thicker and/or made of a foam having coarser pores which has a higher heat insulation capacity.
  • the vapors of the transdermally absorbable active ingredients can accumulate so that they can display their activities over an extended period of time.
  • the metal foil (4) acts at the same time as a baffle and prevents the vapors from prematurely escaping through the foam.
  • the foam layer (6) contiguous to the skin is surface texturizing, some partial aeration and ventilation takes place so that an undesired sweat formation is suppressed. Due to this surface texturizing, a portion of the vapors of the transdermally absorbable active substance can display their effects beyond the punching area.
  • the surface texturizing preferably is in a square pattern spaced 1 to 3 mm apart. The grooves may be about 0.5 to 2 mm in depth.
  • Measurements of the skin temperature under the action of the device of the invention have resulted in the finding that strongest heating occurs at the margins of the carrier (1), namely in the aeration chambers. This result can be explained only by the fact that at said location there is a minimum heat insulation so that the heat collected around the support (2) can be passed back to the body relatively undisturbed and at these locations the vapors of the transdermally absorbable active substances can act on the skin at a relatively high concentration.
  • an impact adhesive or a double-sided adhesive film may be employed.
  • the carriers (1) will be discarded in most of the cases, whereas the support (2) may frequently be re-used. It may also be washed at 30° C. and thereby be kept in hygienic conditions.
  • the transdermally absorbable active substances may include, for example, liquids such as oils, but also tablets, pastes and powders if they have a sufficiently high vapor pressure. More particularly, oils of medicinal herbs may be employed.
  • oils of medicinal herbs include ethereal oils such as camphor oil, green oil, lavender oil, peppermint oil, rosemary oil and turpentine oil as well as mixtures thereof. These oils are administered under condition of long-term warming for a therapeutic treatment of muscle and joint pain, lumbago, sciatica, intervertebral disk and rheumatic problems. They may further be employed for the prophylaxis and after-treatment of sports injuries, strains and contusions. In all these cases there is an increase in the tissue metabolism and an improved blood flow.
  • the means of the invention constitute an excellent applicator, more specifically for medicinal oils and their vapors, whereby the efficiency is intensified and prolonged.
  • a preferred embodiment consists of a magnetically adhesive metal plate (9) or a magnetically adhesive metal wire (10) attached to the surface facing the support (2) of the carrier (1), and in the support (2) there is attached facing the carrier a magnetic foil (11), which has been alternatingly positively and negatively permanently magnetized in the form of stripes, the distance of the magnetized bands from one another being between 3 and 10 mm.
  • the attachment using a magnetically adhesive metal plate (9) or a magnetically adhesive metal wire (10) has been shown to be particularly advantageous, since these metal fastening means may be readily attached to the surface facing the support (2) of the carrier (1), which is the surface remote from the body surface. This may be effected, for example, by interbonding with the nonwoven material or adhesion bonding thereto.
  • the absorbable carrier (1) is on one side firmly bonded to the flexible heat-conductive metal foil (4), it is possible to insert the metal plate (9) or the metal wire (10) between the carrier and the metal foil.
  • the size of the plate (9) may be larger or smaller than the size of the magnetic foil (11). It is preferred that the size of the magnetic plate is of the same order of magnitude as the punched portion (7). Using larger magnetic foils requires higher technical and material expenses. Magnetic foils (11) too small in dimensions fail to ensure a sufficient magnetic attraction of the metal plate (9) or of the metal wire (10).
  • FIG. 1 shows a top plan view of the means in the shape of a plaster.
  • FIG. 2 shows a sectional view of these means.
  • FIG. 3 and FIG. 4 show sectional views of simplified embodiments.
  • FIG. 5, FIG. 6 and FIG. 7 show embodiments derived from those according to the FIGS. 2, 3 and 4, wherein additional metal plates and magnetic foils have been incorporated for attaching the carrier to the support.
  • FIG. 8 shows a top plan view of a carrier (1) comprising a magnetically adhesive metal wire net.
  • FIG. 9 shows an embodiment similar to FIG. 2, including an additional skin compatible layer and Velcro fasteners.
  • FIG. 10 shows the device of the present invention in the shape of a headband.
  • a closed-cell polyethylene foam layer which may optionally be surface texturized or laminated with a fabric
  • (11) a magnetic foil which, in stripe form, has been alternatingly positively and negatively permanently magnetized, the distance of the magnetized stripes from one another being between 3 and 10 mm;
  • the thickness of the polyethylene foam layer (3) is about 2 mm
  • the thickness of the polyethylene foam layer (5) is about 3 mm
  • the thickness of the polyethylene foam layer (6) in original state is also 2 mm
  • 1 to 1.8 mm in the surface texturizing state is also about 1.8 mm.
  • the foam layers usually are somewhat thicker.
  • the removable and replaceable, skin-compatible plaster or the elastic bandage having a Velcro strip fastener for attaching the device of the invention to the skin have not been shown. Due to the fabric layer (8) which preferably consists of Borsched nylon, the self-adhesive plasters as well as the Velcro strip fasteners will adhere sufficiently firmly, while they may be removed again without any damage to the support (2), so that this support (2) may be frequently re-used.
  • a longitudinally extended support 5 to 30 cm in length and 2 to 4 cm in width is prepared wherein one or more portions (7) have been punched and into which appropriate smaller carriers (1) may be inserted.
  • appropriate smaller carriers (1) may be inserted.
  • pads on the other hand, larger dimensions are chosen and also several portions (7) are punched into which appropriately larger carriers (1) may be inserted.

Abstract

A device for the application of heated transdermally absorbable active substances has a carrier impregnated with a transdermally absorbable active substance and a support. The support is a laminate made up of one or more polymeric layers and optionally includes a heat conductive element. A preferred mode of carrier attachment involves the use of a magnetic connector.

Description

This application is a continuation of U.S. application Ser. No. 042,344, filed Apr. 24, 1987, now abandoned.
The present invention relates to a device for the application of transdermally absorbable active substances which allows an intensive and sustained action of the transdermally absorbable active substances over a long period of time and increases the efficiency thereof by simultaneous action of heat.
BACKGROUND OF THE INVENTION
A number of pains, cramps and convulsive disorders are caused by an insufficient or non-uniform blood flow in the outer skin. In many cases alleviation, improvement or even healing may be achieved by a uniform application of heat. The treatment with infrared radiation, warming bottles, heating pads, hot packs and cataplasms always involves considerable trouble and therefore is not always or readily practicable.
It is also known that transdermally absorbable active substances such as, more specifically, oils of officinal herbs, are therapeutically active, particularly when they can display their action over a sufficiently long period of time and have the opportunity of penetrating into the skin. There has already been a long search for possibilities of enhancing the efficiency of the transdermally absorbable active substances.
From the EP-A- 0 0163 045 there are known means for heat insulation and distribution, more specifically of heat of the body, on areas of the outer skin which means consist of a laminate comprising a foam layer, a flexible heat-conducting metal layer and a further foam layer. These means have already proven to be valuable in the form of warming plasters, pads, mats etc.
SUMMARY OF THE INVENTION
It is the object of the present invention to combine said principle of heat therapy with the principle of the application of transdermally absorbable active substances, more specifically of oils from officinal herbs, in order to enhance and optimize the therapeutic activity.
Surprisingly, that object can be effectively and readily attained using means for the application of transdermally absorbable active substances, which means consist of at least one replaceable carrier (1) impregnated with the transdermally absorbable active substances and a support (2) for the carrier consisting of a laminate comprising
(a) a closed-cell polyethylene foam layer (3`) having a thickness of 1 to 5 mm,
(b) a flexible heat-conductive metal foil (4),
(c) a closed-cell polyethylene foam layer (5) having a thickness of 1 to 4 mm, which may optionally be colored,
(d) a closed-cell polyethylene foam layer (6) having a thickness of 1 to 4 mm, which may optionally be surface texturizing, from which at least one portion (7), preferably in pinked shape, has been punched, the size of the area of the portion (7) being equal to or slightly larger than that of the carrier (1), or
(a) a closed-cell polyethylene foam layer (3) having a thickness of 2 to 5 mm,
(b) a flexible heat-conductive metal foil (4),
(c) a closed-cell polyethylene foam layer (6) having a thickness of 2 to 5 mm, which may optionally be surface texturized, from which at least one portion (7), preferably in pinked shape, has been punched, the size of the area of the portion (7) being equal to or slightly larger than that of the carrier (1), or
(a) a closed-cell polyethylene foam layer (3) having a thickness of 2 to 6 mm, which may optionally be colored,
(b) a closed-cell polyethylene foam layer (6) having a thickness of 2 to 5 mm, which may optionally be surface texturized, from which at least one portion (7), preferably in pinked shape, has been punched, the absorptive carrier (1) on one side being firmly bonded to a flexible heat-conductive metal foil (4).
DETAILED DESCRIPTION
To allow easier attachment to the body, the means preferably have a fabric layer (8) on the foam layer (3), which preferably consists of Borsched nylon. This fabric layer allows the means of the invention to be attached to the body by use of skin-compatible self-adhesive plasters or elastic bandages having Velcro or interlocking hook-and-loop type fastners strip fasteners.
The device of the invention may be manufactured in the form of plasters, head-bands or pads, with head-bands and pads comprising several punched pieces (7) and carriers (1) impregnated with transdermally absorbable active substances and replaceably inserted therein.
As the carriers (1) there may preferably be used nonwoven fabrics and, more specifically, any skin-compatible random laid nonwoven fabric having a sufficient rigidity which can be impregnated with the transdermally absorbable active ingredients. However, basically any other sufficiently rigid skin-compatible absorptive carriers which are resistant to transdermally absorbable active substances such as, open-cell foams, fabric etc. may be used. The shape of said impregnated carriers may be selected as desired and, for example, be square, rectangular or polygonal. Particularly simple and preferred is the circular shape. These carriers impregnated with transdermally absorbable active substances either may be freshly prepared by the user or may be supplied sealed in a bag--like refreshment cloths--from the manufacturer.
The size of the punched pieces (7) is equal in area or slightly larger than that of the carrier (1) and is preferrably pinked. This shape provides a good support of the carrier in the recess and, in addition, favors the formation of air chambers at the margin of the carrier in which vapors of the transdermally absorbable substance may accumulate.
The closed-cell polyethylene foam layers (3), (5) and (6) may vary in thickness within the ranges as indicated between 1 and 5 mm or 1 and 6 mm, respectively, while the laminate altogether should be between 5 and 12 mm, and preferably between 6 and 10 mm, in thickness. Thinner laminates are difficult to manufacture and do not provide sufficient storage of heat. Thicker laminates will be too rigid and unhandy and too bulky.
As the flexible heat-conductive metal foil there is mainly used aluminum foil which is preferably 20 to 50 micrometers in thickness.
In a simpler embodiment preferred for manufacturing, the foam layer (5) is omitted, so that the carrier (1) has direct contact with the metal foil (4). This may result in even a more rapid and higher warming of the carrier (1) and, thus, the effect is induced more rapidly and is stronger.
It is also possible to omit the metal film (4) in the support laminate (2) altogether, if the absorptive carrier on one side is firmly bonded to the flexible heatconductive metal foil (4). In this embodiment, it is preferred that the two remaining foam layers (3) and (6) are different in color. Furthermore, in this embodiment, more specifically the layer (3) is selected so that it is thicker and/or made of a foam having coarser pores which has a higher heat insulation capacity.
The astonishing high efficiency of the invention device is due to the following mechanism of action: As is the case with the means according to EP-A 0 163 045, the total laminate of the support (2) causes a good storage and distribution of the body heat to be effected. It has been shown that the feedback of heat to the body is particularly high in the punched portion (7). It is exactly this location where the carrier (1) impregnated with the transdermally absorbable active substances is situated, so that the transdermally absorbable active substances are warmed to a particularly high degree. This results in an increase of the vapor pressure of the transdermally absorbable active ingredients and an increased activity thereof in the area of the punched portions (7). In the air chambers close to the margin of the carrier the vapors of the transdermally absorbable active ingredients can accumulate so that they can display their activities over an extended period of time. The metal foil (4) acts at the same time as a baffle and prevents the vapors from prematurely escaping through the foam.
As it is preferred that the foam layer (6) contiguous to the skin is surface texturizing, some partial aeration and ventilation takes place so that an undesired sweat formation is suppressed. Due to this surface texturizing, a portion of the vapors of the transdermally absorbable active substance can display their effects beyond the punching area. Thus, the surface texturizing preferably is in a square pattern spaced 1 to 3 mm apart. The grooves may be about 0.5 to 2 mm in depth. Instead of surface texturizing, it is also possible to laminate the layer (6) with a fabric layer.
Measurements of the skin temperature under the action of the device of the invention have resulted in the finding that strongest heating occurs at the margins of the carrier (1), namely in the aeration chambers. This result can be explained only by the fact that at said location there is a minimum heat insulation so that the heat collected around the support (2) can be passed back to the body relatively undisturbed and at these locations the vapors of the transdermally absorbable active substances can act on the skin at a relatively high concentration.
In the manufacture of the support (2), there basically exists a possibility of integrally making the polyethylene foam layers (5) and (6), or (4) and (6), or even (3) and (6), respectively, and then therefrom to punch the portion (7) in such a manner that still up to 4 mm of the foam layer can remain between the support (1) and the metal foil (4). However, from the standpoint of manufacturing engineering such a procedure will be substantially more difficult than to laminate the respective two partial layers to each other as set forth hereinabove. This has another advantage in that the foam layers (5) and/or (3), respectively, may be colored, so that the punched portion (7) becomes clearly visible. This facilitates inserting the carrier (1) into the punched portion. Instead of punching said portion; (7), it is of course also possible to hot-emboss said portion which procedure, however, will hardly produce sharper pinks. In order to effect an improved attachment of the carrier (1) to the support (2), an impact adhesive or a double-sided adhesive film may be employed.
After the application, the carriers (1) will be discarded in most of the cases, whereas the support (2) may frequently be re-used. It may also be washed at 30° C. and thereby be kept in hygienic conditions.
The transdermally absorbable active substances may include, for example, liquids such as oils, but also tablets, pastes and powders if they have a sufficiently high vapor pressure. More particularly, oils of medicinal herbs may be employed. The preferred oils of medicinal herbs include ethereal oils such as camphor oil, green oil, lavender oil, peppermint oil, rosemary oil and turpentine oil as well as mixtures thereof. These oils are administered under condition of long-term warming for a therapeutic treatment of muscle and joint pain, lumbago, sciatica, intervertebral disk and rheumatic problems. They may further be employed for the prophylaxis and after-treatment of sports injuries, strains and contusions. In all these cases there is an increase in the tissue metabolism and an improved blood flow. Thus, the means of the invention constitute an excellent applicator, more specifically for medicinal oils and their vapors, whereby the efficiency is intensified and prolonged.
When the means according to the invention were tested, it was found that, particularly upon repeated use of the support, the carriers are no longer sufficiently supported and tend to come loose or displaced from their pre-determined positions. Although, basically, the carrier may be attached to the support by an impact adhesive or a piece of double-sided adhesive film, the following additional fastening means have proven to be better suitable. Velcro strip fasteners (13) are attached to the surface facing the support (2) of the carrier (1) as well as to the surface facing the carrier (1). A preferred embodiment consists of a magnetically adhesive metal plate (9) or a magnetically adhesive metal wire (10) attached to the surface facing the support (2) of the carrier (1), and in the support (2) there is attached facing the carrier a magnetic foil (11), which has been alternatingly positively and negatively permanently magnetized in the form of stripes, the distance of the magnetized bands from one another being between 3 and 10 mm.
The reversible attachment using a Velcro strip fastener is relatively simple and inexpensive to effect. However, the Velcro strip fastener has the drawback of that it is rather bulky and, thus, results in an undesired bulging of the device of the invention. Thus, one will accept this drawback only for devices in which a higher total thickness is acceptable.
The attachment using a magnetically adhesive metal plate (9) or a magnetically adhesive metal wire (10) has been shown to be particularly advantageous, since these metal fastening means may be readily attached to the surface facing the support (2) of the carrier (1), which is the surface remote from the body surface. This may be effected, for example, by interbonding with the nonwoven material or adhesion bonding thereto. In the embodiment in which the absorbable carrier (1) is on one side firmly bonded to the flexible heat-conductive metal foil (4), it is possible to insert the metal plate (9) or the metal wire (10) between the carrier and the metal foil.
As the magnetically adhesive metal plate or magnetically adhesive metal wire there may be used in particular iron, but also other ferromagnetic alloy or metals. When iron or steel is employed, it may be expedient, for reasons of protection from corrosion, to use iron plates or iron wires the surfaces of which have been zinc-plated or otherwise protected from corrosion.
As the magnetic foils, which have been alternatingly positively and negatively permanently magnetized in stripe form and wherein the distance of the magnetized stripes from one another is between 3 and 10 mm, there are suitable commercially available magnetic foils which are supplied in thicknesses of between 0.5 and 2 mm, and preferably between 1.0 and 1.5 mm, and have been alternatingly magnetized in the desired manner. The stripes may be linear or circular so that the magnetic stripes are arranged as concentric rings.
The distance of the magnetized stripes of between 3 and 10 mm ensures a good adhesion of the metal plates or of the metal wire to be effected due to magnetic attraction, even if they are not close to each other. This is due to the fact that stripe-shaped magnetic foils alternatingly positively and negatively permanently magnetized produce a sufficiently strong magnetic field even at a distance of some millimeters.
The size of the plate (9) may be larger or smaller than the size of the magnetic foil (11). It is preferred that the size of the magnetic plate is of the same order of magnitude as the punched portion (7). Using larger magnetic foils requires higher technical and material expenses. Magnetic foils (11) too small in dimensions fail to ensure a sufficient magnetic attraction of the metal plate (9) or of the metal wire (10).
Although it would basically be possible to interchange the positions of metal plate (9) or of metal wire (10), respectively, with the position of the magnetic foil (11), this would in fact mean that the carrier, only used once, would be disposed of together with the relatively expensive magnetic foil, whereas in the claimed embodiment the magnetic foil can be used several times together with the support (2).
It has also been shown that in some cases it may be advantageous in the device of the invention to cover the surface of the support (2) facing the skin with a skin-compatible material (12). To this purpose, it is preferred to laminate a thin cotton fabric or an otherwise skin-compatible fabric with a pre-fabricated adhesive layer such as, for example, the product Mefix of the firm Molnlycke.
Preferred embodiments of the means according to the invention for the application of transdermally absorbable active substances are shown in the Figures of the attached drawing.
FIG. 1 shows a top plan view of the means in the shape of a plaster.
FIG. 2 shows a sectional view of these means.
FIG. 3 and FIG. 4 show sectional views of simplified embodiments.
FIG. 5, FIG. 6 and FIG. 7 show embodiments derived from those according to the FIGS. 2, 3 and 4, wherein additional metal plates and magnetic foils have been incorporated for attaching the carrier to the support.
FIG. 8 shows a top plan view of a carrier (1) comprising a magnetically adhesive metal wire net.
FIG. 9 shows an embodiment similar to FIG. 2, including an additional skin compatible layer and Velcro fasteners.
FIG. 10 shows the device of the present invention in the shape of a headband.
In the Figures, like parts have been designated by like reference numerals which have the following meanings:
(1) a carrier impregnated with a transdermally absorbable active substance;
(2) the entire support;
(3) a closed-cell polyethylene foam layer;
(4) a flexible heat-conductive metal foil;
(5) a closed-cell polyethylene foam layer which may optionally be colored;
(6) a closed-cell polyethylene foam layer which may optionally be surface texturized or laminated with a fabric;
(7) a portion punched in pinked shape;
(8) a fabric layer made of Borsched nylon;
(9) a magnetically adhesive metal plate;
(10) a magnetically adhesive metal wire;
(11) a magnetic foil which, in stripe form, has been alternatingly positively and negatively permanently magnetized, the distance of the magnetized stripes from one another being between 3 and 10 mm;
(12) a skin compatible layer; and
(13) Velcro interlocking hook-and-loop type fasteners.
In this preferred embodiment according to FIG. 2 the thickness of the polyethylene foam layer (3) is about 2 mm, the thickness of the polyethylene foam layer (5) is about 3 mm, and the thickness of the polyethylene foam layer (6) in original state is also 2 mm, and 1 to 1.8 mm in the surface texturizing state. Hence, the depth of the punched portion (7) is also about 1.8 mm. In the embodiments according to the FIGS. 3 and 4 the foam layers usually are somewhat thicker.
The removable and replaceable, skin-compatible plaster or the elastic bandage having a Velcro strip fastener for attaching the device of the invention to the skin have not been shown. Due to the fabric layer (8) which preferably consists of Borsched nylon, the self-adhesive plasters as well as the Velcro strip fasteners will adhere sufficiently firmly, while they may be removed again without any damage to the support (2), so that this support (2) may be frequently re-used.
The punched portion (7) according to FIG. 1 is pinked in such a manner that saw-tooth-shaped aeration chambers are formed. Together with the inlaid carrier there is formed the image of flower leaves or of the aureole of a sun. However, basically there may be used linear or even wavily curved dents and, thus, rounded dents may be employed, if they are capable of sufficiently supporting the carrier (1) impregnated with the transdermally absorbable active substances.
For the manufacture of an appropriate head band, a longitudinally extended support 5 to 30 cm in length and 2 to 4 cm in width is prepared wherein one or more portions (7) have been punched and into which appropriate smaller carriers (1) may be inserted. For the manufacture of pads, on the other hand, larger dimensions are chosen and also several portions (7) are punched into which appropriately larger carriers (1) may be inserted.

Claims (22)

What is claimed is:
1. A device for application of a heated transdermally absorbable active substance to skin, comprising at least one replaceable carrier impregnated with a transdermally absorbable active substance, and a laminate support housing the carrier comprising:
(a) a first closed-cell polyethylene foam layer having a thickness of 2 to 6 mm, said first foam layer including a foil-facing area and a laminate-contacting area defined on a first surface, and an opposite surface,
(b) a second closed-cell polyethylene foam layer having a thickness of 2 to 5 mm, said second foam layer including a laminate-contacting surface bonded to said laminate-contacting area of the first foam layer and an opposite, skin-contacting surface, wherein at least one portion of said second foam layer has been removed to define pink-shaped side walls housing the carrier, and
(c) a flexible heat-conductive metal foil, said metal foil including a first surface facing said foil-contacting surface of the first foam layer and an opposite surface facing said carrier.
2. A device according to claim 1, further comprising a fabric layer laminated onto the opposite surface of the first foam layer.
3. A device according to claim 1, wherein the skin-contacting surface of said second foam layer is covered with a skin-compatible fabric.
4. A device according to claim 1, wherein the support is in the shape of a headband.
5. A device according to claim 1, wherein the support is in the shape of a pad.
6. A device according to claim 1, wherein the skin-contacting surface of the second foam layer is surface texturized.
7. A device for application of a heated transdermally absorbable active substance to skin, comprising at least one replaceable carrier impregnated with a transdermally absorbable active substance, and a laminate support housing the carrier comprising:
(a) a first closed-cell polyethylene foam layer having a thickness of 1 to 5 mm, said first foam layer including a foil-bonding surface and an opposite surface,
(b) a flexible heat-conductive metal foil including a surface bonded to said foil-bonding surface of the first foam layer, and an opposite surface,
(c) a second closed-cell polyethylene foam layer having a thickness of 1 to 4 mm, said second foam layer including a surface bonded to said opposite surface of the metal foil, and an opposite surface, and
(d) a third closed-cell polyethylene foam layer having a thickness of 1 to 4 mm, said third foam layer including a laminate-contacting surface bonded to said opposite surface of the second foam layer and an opposite, skin-contacting surface, wherein at least one portion of said third foam layer has been removed to define side walls surrounding an area housing the carrier, the size of the housing area being equal to or slightly larger than the surface area of the carrier.
8. A device according to claim 7, wherein said side walls define a pinked shape.
9. A device according to claim 7, further comprising a fabric layer laminated onto the opposite surface of the first foam layer.
10. A device according to claim 7, wherein the support is in the shape of a headband.
11. A device according to claim 7, wherein the support is in the shape of a pad.
12. A device according to claim 7, wherein the skin-contacting surface of said third foam layer is covered with a skin-compatible fabric.
13. A device according to claim 7, further comprising a multiple interlocking hook-and-loop type fastener attaching said carrier to said support, said fastener including one side attached to a non-skin-contacting, support-facing surface of the carrier and an opposing side, interlocking with said one side, attached to an area of the opposite surface of the second foam layer facing the carrier, said area of the opposite surface of the second foam layer defining a bottom wall covering the housing area.
14. A device according to claim 7, wherein the skin-contacting surface of the third foam layer is surface texturized.
15. A device for application of a heated transdermally absorbable active substance to skin, comprising at least one replaceable carrier impregnated with a transdermally absorbable active substance, and a laminate support housing the carrier comprising:
(a) a first closed-cell polyethylene foam layer having a thickness of 2 to 5 mm, said first foam layer including a foil-bonding surface and an opposite surface,
(b) a flexible heat-conductive metal foil including a surface bonded to said foil-bonding surface of the first foam layer, and an opposite surface,
(c) a second closed-cell polyethylene foam layer having a thickness of 2 to 5 mm, said second foam layer including a laminate-contacting surface bonded to said opposite surface of the foil and an opposite, skin-contacting surface, wherein at least one portion of said second foam layer has been removed to define side walls surrounding an area housing the carrier, the size of the housing area being equal to or slightly larger than the surface area of the carrier.
16. A device according to claim 15, wherein said side walls define a pinked shaped.
17. A device according to claim 15, further comprising a fabric layer laminated onto the opposite surface of the first foam layer.
18. A device according to claim 15, wherein the support is in the shape of a headband.
19. A device according to claim 15, wherein the support is in the shape of a pad.
20. A device according to claim 15, wherein the skin-contacting surface of said second foam layer is covered with a skin-compatible fabric.
21. A device according to claim 15, further comprising a multiple interlocking hook-and-loop type fastener attaching said carrier to said support, said fastener including one side attached to a non-skin-contacting, support-facing surface of the carrier and an opposing side, interlocking with said one side, attached to an area of the opposite surface of the second foam layer facing the carrier, said area of the opposite surface of the second foam layer defining a bottom wall covering the housing area.
22. A device according to claim 15, wherein the skin-contacting surface of the second foam layer is surface texturized.
US07/245,923 1986-08-23 1988-09-16 Means for the application of transdermally absorbable active substances Expired - Fee Related US4898592A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE3628688 1986-08-23
DE3628688 1986-08-23
DE3629565 1986-08-30
DE19863629565 DE3629565A1 (en) 1986-08-30 1986-08-30 Means for the application of transdermally absorbable active ingredients
EP87102306.5 1987-02-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US07042344 Continuation 1987-04-24

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US07/436,709 Continuation US4994049A (en) 1986-08-23 1989-11-15 Device for applying a substance to the skin

Publications (1)

Publication Number Publication Date
US4898592A true US4898592A (en) 1990-02-06

Family

ID=25846824

Family Applications (2)

Application Number Title Priority Date Filing Date
US07/245,923 Expired - Fee Related US4898592A (en) 1986-08-23 1988-09-16 Means for the application of transdermally absorbable active substances
US07/436,709 Expired - Fee Related US4994049A (en) 1986-08-23 1989-11-15 Device for applying a substance to the skin

Family Applications After (1)

Application Number Title Priority Date Filing Date
US07/436,709 Expired - Fee Related US4994049A (en) 1986-08-23 1989-11-15 Device for applying a substance to the skin

Country Status (5)

Country Link
US (2) US4898592A (en)
EP (1) EP0258521B1 (en)
KR (1) KR880002545A (en)
AU (1) AU594805B2 (en)
DE (1) DE3762480D1 (en)

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994049A (en) * 1986-08-23 1991-02-19 Latzke Arno W Device for applying a substance to the skin
WO1991013677A1 (en) * 1990-03-07 1991-09-19 Shettigar U Ramakrishna Autologous blood recovery membrane system and method
US5531670A (en) * 1992-01-17 1996-07-02 Anette Dobloug Heat conserving bandage
WO1997004728A1 (en) * 1995-07-28 1997-02-13 Zars, Inc. Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
WO2000018338A1 (en) * 1998-09-29 2000-04-06 Zars, Inc. Methods and apparatus for improved administration of fentanyl and sufentanil
WO2000018339A1 (en) * 1998-09-29 2000-04-06 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
WO2001003619A1 (en) 1999-07-08 2001-01-18 Johnson & Johnson Consumer Companies, Inc. Exothermic topical delivery device
US6245347B1 (en) 1995-07-28 2001-06-12 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
US6261595B1 (en) 2000-02-29 2001-07-17 Zars, Inc. Transdermal drug patch with attached pocket for controlled heating device
GB2369055A (en) * 2000-10-25 2002-05-22 Joanna Maw Coloured essential oil skin patch
DE10058323A1 (en) * 2000-11-24 2002-06-06 Seifert Heinz Juergen Bandage contains devices which emit field and medically active material, side applied to skin being porous and opposite side gas- and liquid-impermeable
US6453648B1 (en) 1999-07-06 2002-09-24 Zars, Inc. Method for manufacturing a heat generating apparatus
US20030118779A1 (en) * 2001-12-20 2003-06-26 Kimberly-Clark Worlwide, Inc. Activatable laminate structures
US20040071760A1 (en) * 2002-01-07 2004-04-15 Israel Dvoretzky Therapeutic film forming composition and treatment system therefor
US6726673B1 (en) 1999-05-24 2004-04-27 Zars, Inc. Methods and apparatus for improved administration of testosterone pharmaceuticals
US20040265353A1 (en) * 1995-07-28 2004-12-30 Zars, Inc. Systems and methods for treating panic attacks
US6890553B1 (en) 1999-07-08 2005-05-10 Johnson & Johnson Consumer Companies, Inc. Exothermic topical delivery device
US6955819B2 (en) 1998-09-29 2005-10-18 Zars, Inc. Methods and apparatus for using controlled heat to regulate transdermal and controlled release delivery of fentanyl, other analgesics, and other medical substances
US20060078600A1 (en) * 2003-02-07 2006-04-13 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof
US20060088686A1 (en) * 2004-10-25 2006-04-27 Stein Celeste A Art wrap bandage
US20080281297A1 (en) * 2007-03-19 2008-11-13 Benny Pesach Method and device for drug delivery
US20080299182A1 (en) * 2007-03-01 2008-12-04 Shuyuan Zhang Methods and formulations for topical gene therapy
US20100152644A1 (en) * 2007-03-19 2010-06-17 Insuline Medical Ltd. Method and device for drug delivery
US20100174225A1 (en) * 2007-03-19 2010-07-08 Benny Pesach Drug delivery device
US20100286467A1 (en) * 2007-03-19 2010-11-11 Benny Pesach Device for drug delivery and associated connections thereto
US20110015229A1 (en) * 2009-01-06 2011-01-20 Jie Zhang Method of treating neuropathic pain
US20110086913A1 (en) * 2009-04-01 2011-04-14 Jie Zhang Methods for treating myofascial, muscle, and/or back pain
US20110112189A1 (en) * 2009-05-04 2011-05-12 Jie Zhang Methods of treating pains associated with neuroma, nerve entrapment, and other conditions
CN1899644B (en) * 1998-09-29 2012-12-12 沙斯公司 Methods and apparatus for improved administration of pharmaceutically active compounds
US8409133B2 (en) 2007-12-18 2013-04-02 Insuline Medical Ltd. Drug delivery device with sensor for closed-loop operation
US8961458B2 (en) 2008-11-07 2015-02-24 Insuline Medical Ltd. Device and method for drug delivery
US9186334B2 (en) 2009-05-04 2015-11-17 Nuvo Research Inc. Heat assisted lidocaine and tetracaine for transdermal analgesia
US9693976B2 (en) 2010-01-14 2017-07-04 Crescita Therapeutics Inc. Solid-forming local anesthetic formulations for pain control

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3838061A1 (en) * 1988-11-10 1990-05-23 Holzer Walter STERILE SELF-ADHESIVE FILM FOR MEDICAL PREPARATION
DE3839625A1 (en) * 1988-11-24 1990-05-31 Ralf Latzke Device for administration of transdermally absorbable active substances
KR900701347A (en) * 1988-11-24 1990-12-01 라츠케 랄프 Percutaneously reabsorbable active substance application device
DE3844247A1 (en) * 1988-12-29 1990-07-12 Minnesota Mining & Mfg DEVICE, IN PARTICULAR PLASTER FOR TRANSDERMAL ADMINISTRATION OF A MEDICINAL PRODUCT
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
FR2703242B1 (en) * 1993-03-30 1995-07-07 Provence Sa Argiles Haute Specific clay-based poultices and manufacturing process.
WO1994028854A1 (en) * 1993-06-11 1994-12-22 Koeltringer Peter Process and device for treating body tissues
DE19519593C1 (en) * 1995-05-29 1996-08-29 Horstmann Michael Transdermal therapeutic system with thermoplastic back layer
US5792090A (en) * 1995-06-15 1998-08-11 Ladin; Daniel Oxygen generating wound dressing
US7063859B1 (en) 1999-04-28 2006-06-20 Noven Pharmaceuticals, Inc. Barrier film lined backing layer composition and method for topical administration of active agents
EP1506035A1 (en) * 2002-05-06 2005-02-16 Vectura Limited Application device for topical administration of pharmaceutical agents
US7320801B2 (en) * 2005-09-26 2008-01-22 Jack Perez Kelly Patch for treating symptoms of a skin abscess
DE102007006244B4 (en) * 2007-02-08 2012-03-15 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for the administration of water-soluble drugs
AU2008355879A1 (en) * 2008-05-07 2009-11-12 International Scientific Pty Ltd Method and apparatus for enhanced transdermal diffusion
US8939953B2 (en) 2010-10-18 2015-01-27 Weiru Shao Methods of using multilayer medical sponges
US20110066124A1 (en) * 2010-10-18 2011-03-17 Weiru Shao Multilayer Medical Sponge
AU2013212528B2 (en) * 2012-01-24 2017-10-05 International Scientific Pty Ltd Delivery device
US8894314B2 (en) * 2012-03-22 2014-11-25 Richard P. Morrow Travel deodorant dispenser
US9486057B2 (en) * 2012-03-22 2016-11-08 Richard P. Morrow Single-mould deodorant dispenser in travel package
CN107714291A (en) * 2017-10-11 2018-02-23 赵坚 A kind of ventilative drug paste

Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1862122A (en) * 1929-10-03 1932-06-07 William L Schrader Plaster and package therefor
US2344021A (en) * 1942-09-05 1944-03-14 Bouziane George Surgical bandage
US3026874A (en) * 1959-11-06 1962-03-27 Robert C Stevens Wound shield
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3674027A (en) * 1969-08-06 1972-07-04 Raul Fleischmajer Disposable wet compresses
US3777754A (en) * 1972-11-13 1973-12-11 W Plachy Medicated disposable pad
DE2301821A1 (en) * 1973-01-15 1974-08-01 Georg Hubmann Medicinal mud pack with high thermal storage - obtd. by reflective and insulating outer facing, pref. contained in tear off protective casing
US3837340A (en) * 1971-10-20 1974-09-24 Lilly Co Eli Device for administering immunication against virus
DE2722273A1 (en) * 1977-05-17 1978-11-30 Klaus Homann Rheumatic plaster construction - has a thin layer of foam to give thermal insulation and heat retention
US4230105A (en) * 1978-11-13 1980-10-28 Merck & Co., Inc. Transdermal delivery of drugs
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US4297995A (en) * 1980-06-03 1981-11-03 Key Pharmaceuticals, Inc. Bandage containing attachment post
US4460372A (en) * 1981-02-17 1984-07-17 Alza Corporation Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
EP0136393A1 (en) * 1983-10-05 1985-04-10 Lacotherm Ag Magnetic sheets
FR2561505A1 (en) * 1984-02-23 1985-09-27 Matola Edith Device for distributing active agents intended for hygienic care of the face and scalp
US4564010A (en) * 1984-04-18 1986-01-14 Daubert Coated Products Inc. Pressure sensitive adhesive film for medical use
US4592753A (en) * 1982-12-13 1986-06-03 Elan Corporation P.L.C. Drug delivery device
US4595391A (en) * 1984-01-10 1986-06-17 George Abplanalp Ointment applicator
US4605399A (en) * 1984-12-04 1986-08-12 Complex, Inc. Transdermal infusion device
US4695277A (en) * 1984-08-17 1987-09-22 Allpack Industrielle Lohnverpackung Gmbh & Co. Kg Pharmaceutical adhesive plaster and method for manufacturing it
US4710191A (en) * 1985-12-16 1987-12-01 Jonergin, Inc. Therapeutic device for the administration of medicaments
US4765986A (en) * 1985-06-20 1988-08-23 Liedtke Pharmed Gmbh Medicinal plaster for systemic use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE54286B1 (en) * 1983-01-18 1989-08-16 Elan Corp Plc Drug delivery device
GB8319096D0 (en) * 1983-07-14 1983-08-17 Harlands Of Hull Ltd Topical dressings
US4743249A (en) * 1986-02-14 1988-05-10 Ciba-Geigy Corp. Dermal and transdermal patches having a discontinuous pattern adhesive layer
EP0258521B1 (en) * 1986-08-23 1990-05-02 Arno Walter Latzke Means for applying media by percutany

Patent Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1862122A (en) * 1929-10-03 1932-06-07 William L Schrader Plaster and package therefor
US2344021A (en) * 1942-09-05 1944-03-14 Bouziane George Surgical bandage
US3026874A (en) * 1959-11-06 1962-03-27 Robert C Stevens Wound shield
US3598122B1 (en) * 1969-04-01 1982-11-23
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3674027A (en) * 1969-08-06 1972-07-04 Raul Fleischmajer Disposable wet compresses
US3837340A (en) * 1971-10-20 1974-09-24 Lilly Co Eli Device for administering immunication against virus
US3777754A (en) * 1972-11-13 1973-12-11 W Plachy Medicated disposable pad
DE2301821A1 (en) * 1973-01-15 1974-08-01 Georg Hubmann Medicinal mud pack with high thermal storage - obtd. by reflective and insulating outer facing, pref. contained in tear off protective casing
DE2722273A1 (en) * 1977-05-17 1978-11-30 Klaus Homann Rheumatic plaster construction - has a thin layer of foam to give thermal insulation and heat retention
US4230105A (en) * 1978-11-13 1980-10-28 Merck & Co., Inc. Transdermal delivery of drugs
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US4297995A (en) * 1980-06-03 1981-11-03 Key Pharmaceuticals, Inc. Bandage containing attachment post
US4460372A (en) * 1981-02-17 1984-07-17 Alza Corporation Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
US4592753A (en) * 1982-12-13 1986-06-03 Elan Corporation P.L.C. Drug delivery device
EP0136393A1 (en) * 1983-10-05 1985-04-10 Lacotherm Ag Magnetic sheets
US4595391A (en) * 1984-01-10 1986-06-17 George Abplanalp Ointment applicator
FR2561505A1 (en) * 1984-02-23 1985-09-27 Matola Edith Device for distributing active agents intended for hygienic care of the face and scalp
US4564010A (en) * 1984-04-18 1986-01-14 Daubert Coated Products Inc. Pressure sensitive adhesive film for medical use
US4695277A (en) * 1984-08-17 1987-09-22 Allpack Industrielle Lohnverpackung Gmbh & Co. Kg Pharmaceutical adhesive plaster and method for manufacturing it
US4605399A (en) * 1984-12-04 1986-08-12 Complex, Inc. Transdermal infusion device
US4765986A (en) * 1985-06-20 1988-08-23 Liedtke Pharmed Gmbh Medicinal plaster for systemic use
US4710191A (en) * 1985-12-16 1987-12-01 Jonergin, Inc. Therapeutic device for the administration of medicaments

Cited By (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994049A (en) * 1986-08-23 1991-02-19 Latzke Arno W Device for applying a substance to the skin
WO1991013677A1 (en) * 1990-03-07 1991-09-19 Shettigar U Ramakrishna Autologous blood recovery membrane system and method
US5531670A (en) * 1992-01-17 1996-07-02 Anette Dobloug Heat conserving bandage
US6340472B1 (en) 1995-07-28 2002-01-22 Zars, Inc. Method for reducing onset time of pharmaceutically active compounds
US6284266B1 (en) 1995-07-28 2001-09-04 Zars, Inc. Methods and apparatus for improved administration of fentanyl and sufentanil
US6546281B1 (en) 1995-07-28 2003-04-08 Zars, Inc. Integrated apparatus for controlled heat aided dermal drug delivery
US5919479A (en) * 1995-07-28 1999-07-06 Zars, Inc. Noninvasive dermal anesthetics
EP2279713A3 (en) * 1995-07-28 2011-03-30 ZARS Pharma, Inc. Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
EP2279713A2 (en) 1995-07-28 2011-02-02 Zars, Inc. Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
CN100515418C (en) * 1995-07-28 2009-07-22 扎尔斯股份有限公司 Methods and apparatus for improved administration of analgesics
US6245347B1 (en) 1995-07-28 2001-06-12 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
WO1997004728A1 (en) * 1995-07-28 1997-02-13 Zars, Inc. Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
US5658583A (en) * 1995-07-28 1997-08-19 Zhang; Jie Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
US6303142B1 (en) 1995-07-28 2001-10-16 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
US6306431B1 (en) 1995-07-28 2001-10-23 Zars, Inc. Apparatus for heating to a desired temperature for improved administration of pharmaceutically active compounds
US20030138464A1 (en) * 1995-07-28 2003-07-24 Jie Zhang Method and apparatus for improved heat controlled administration of pharmaceuticals
US20040265353A1 (en) * 1995-07-28 2004-12-30 Zars, Inc. Systems and methods for treating panic attacks
US6780426B2 (en) 1995-07-28 2004-08-24 Zars, Inc. Method and apparatus for improved heat controlled administration of pharmaceuticals
US20030219470A1 (en) * 1995-07-28 2003-11-27 Jie Zhang Electrical apparatus for heating to a desired temperature for improved administration of pharmaceutically active compounds
US6465006B1 (en) 1995-07-28 2002-10-15 Zars, Inc. Method for facilitating absorption of pharmaceutically active compounds
US6613350B1 (en) 1995-07-28 2003-09-02 Zars, Inc. Electrical apparatus for heating to a desired temperature for improved administration of pharmaceutically active compounds
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
US6955819B2 (en) 1998-09-29 2005-10-18 Zars, Inc. Methods and apparatus for using controlled heat to regulate transdermal and controlled release delivery of fentanyl, other analgesics, and other medical substances
WO2000018339A1 (en) * 1998-09-29 2000-04-06 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
WO2000018338A1 (en) * 1998-09-29 2000-04-06 Zars, Inc. Methods and apparatus for improved administration of fentanyl and sufentanil
CN1899644B (en) * 1998-09-29 2012-12-12 沙斯公司 Methods and apparatus for improved administration of pharmaceutically active compounds
CN100402001C (en) * 1998-09-29 2008-07-16 沙斯公司 Methods and appts. for improved administration of fentanyl and supentanil
US6726673B1 (en) 1999-05-24 2004-04-27 Zars, Inc. Methods and apparatus for improved administration of testosterone pharmaceuticals
US6453648B1 (en) 1999-07-06 2002-09-24 Zars, Inc. Method for manufacturing a heat generating apparatus
US6890553B1 (en) 1999-07-08 2005-05-10 Johnson & Johnson Consumer Companies, Inc. Exothermic topical delivery device
WO2001003619A1 (en) 1999-07-08 2001-01-18 Johnson & Johnson Consumer Companies, Inc. Exothermic topical delivery device
US6261595B1 (en) 2000-02-29 2001-07-17 Zars, Inc. Transdermal drug patch with attached pocket for controlled heating device
US6488959B2 (en) 2000-02-29 2002-12-03 Zars, Inc. Transdermal drug patch with attached pocket for controlled heating device
GB2369055A (en) * 2000-10-25 2002-05-22 Joanna Maw Coloured essential oil skin patch
DE10058323A1 (en) * 2000-11-24 2002-06-06 Seifert Heinz Juergen Bandage contains devices which emit field and medically active material, side applied to skin being porous and opposite side gas- and liquid-impermeable
US20030118779A1 (en) * 2001-12-20 2003-06-26 Kimberly-Clark Worlwide, Inc. Activatable laminate structures
US7083839B2 (en) 2001-12-20 2006-08-01 Kimberly-Clark Worldwide, Inc. Laminate structures containing activatable materials
US20040071760A1 (en) * 2002-01-07 2004-04-15 Israel Dvoretzky Therapeutic film forming composition and treatment system therefor
US20060078600A1 (en) * 2003-02-07 2006-04-13 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof
US20060088686A1 (en) * 2004-10-25 2006-04-27 Stein Celeste A Art wrap bandage
US7988742B2 (en) * 2004-10-25 2011-08-02 Celeste Ann Stein Art wrap bandage
US20080299182A1 (en) * 2007-03-01 2008-12-04 Shuyuan Zhang Methods and formulations for topical gene therapy
US8622991B2 (en) 2007-03-19 2014-01-07 Insuline Medical Ltd. Method and device for drug delivery
US20100286467A1 (en) * 2007-03-19 2010-11-11 Benny Pesach Device for drug delivery and associated connections thereto
US9056167B2 (en) 2007-03-19 2015-06-16 Insuline Medical Ltd. Method and device for drug delivery
US20100152644A1 (en) * 2007-03-19 2010-06-17 Insuline Medical Ltd. Method and device for drug delivery
US20100174225A1 (en) * 2007-03-19 2010-07-08 Benny Pesach Drug delivery device
US8827979B2 (en) 2007-03-19 2014-09-09 Insuline Medical Ltd. Drug delivery device
US20080281297A1 (en) * 2007-03-19 2008-11-13 Benny Pesach Method and device for drug delivery
US9220837B2 (en) 2007-03-19 2015-12-29 Insuline Medical Ltd. Method and device for drug delivery
US8409133B2 (en) 2007-12-18 2013-04-02 Insuline Medical Ltd. Drug delivery device with sensor for closed-loop operation
US9731084B2 (en) 2008-11-07 2017-08-15 Insuline Medical Ltd. Device and method for drug delivery
US8961458B2 (en) 2008-11-07 2015-02-24 Insuline Medical Ltd. Device and method for drug delivery
US9012477B2 (en) 2009-01-06 2015-04-21 Nuvo Research Inc. Method of treating neuropathic pain
US20110015229A1 (en) * 2009-01-06 2011-01-20 Jie Zhang Method of treating neuropathic pain
US20110086913A1 (en) * 2009-04-01 2011-04-14 Jie Zhang Methods for treating myofascial, muscle, and/or back pain
US9186273B2 (en) 2009-05-04 2015-11-17 Nuvo Research Inc. Methods of treating pains associated with neuroma, nerve entrapment, and other conditions
US9186334B2 (en) 2009-05-04 2015-11-17 Nuvo Research Inc. Heat assisted lidocaine and tetracaine for transdermal analgesia
US20110112189A1 (en) * 2009-05-04 2011-05-12 Jie Zhang Methods of treating pains associated with neuroma, nerve entrapment, and other conditions
US9693976B2 (en) 2010-01-14 2017-07-04 Crescita Therapeutics Inc. Solid-forming local anesthetic formulations for pain control
US10350180B2 (en) 2010-01-14 2019-07-16 Crescita Therapeutics Inc. Solid-forming local anesthetic formulations for pain control
US10603293B2 (en) 2010-01-14 2020-03-31 Crescita Therapeutics Inc. Solid-forming local anesthetic formulations for pain control
US10751305B2 (en) 2010-01-14 2020-08-25 Crescita Therapeutics Inc. Solid-forming topical formulations for pain control

Also Published As

Publication number Publication date
AU7711787A (en) 1988-02-25
EP0258521A1 (en) 1988-03-09
EP0258521B1 (en) 1990-05-02
US4994049A (en) 1991-02-19
KR880002545A (en) 1988-05-09
DE3762480D1 (en) 1990-06-07
AU594805B2 (en) 1990-03-15

Similar Documents

Publication Publication Date Title
US4898592A (en) Means for the application of transdermally absorbable active substances
CA2052049C (en) Reusable and microwavable hot or cold therapy mitt and method of manufacture
US20120232448A1 (en) New kinesiology tape
US5837004A (en) Device for treatment of temporomandibular joint dysfunction
JP2753193B2 (en) Nose warmer
EP0214368B1 (en) Means for raising and stabilizing skin temperature
WO2011001553A1 (en) Tool for prevention or treatment of hemorrhoid, and method for prevention or treatment of hemorrhoid
DE3629565A1 (en) Means for the application of transdermally absorbable active ingredients
KR102312099B1 (en) Patch Device for Heating of Abdominal Region
JPH0335948B2 (en)
US20120046513A1 (en) Magnetic Hot / Cold Pack
EP0650711A1 (en) A device for preventing or reducing the incidence or intensity of pain in the body
JP2003116902A (en) Functional sheet
JPH042365A (en) Therapeutic device for analgesic use
AU596607B2 (en) Means for increasing and stabilizing the skin temperature
US7732656B2 (en) Minimal contact treatment device
JPH0325799Y2 (en)
JP2003252753A (en) External cataplasm
JPH02174861A (en) Hyperthermia sheet
CN214710534U (en) Warming appliance
JP2002345876A (en) Thermo-sheet
JPH03146074A (en) Hot compress
JPS6142590Y2 (en)
JP2002143206A (en) Cold protection utensil which warms medically sensitive spots
JPS609223Y2 (en) medicinal patch sheet

Legal Events

Date Code Title Description
REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
FP Lapsed due to failure to pay maintenance fee

Effective date: 19930206

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362